Use our new account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

amicus brief

amicus brief

3 results

Filter Results By

Filter Applied. Clear All

Latest Posts

October 2, 2023 Why We Need Federal Limits on Late Abortion to Protect Both Mother and Child Why We Need Federal Limits on Late Abortion to Protect Both Mother and Child September 27, 2023 Charlotte Lozier Scholars Discuss Bioethical Challenges and Exploiting Nascent Human Beings Charlotte Lozier Scholars Discuss Bioethical Challenges and Exploiting Nascent Human Beings September 22, 2023 Twelve Reasons Women’s Health and Maternal Mortality Will Not Worsen, and May Improve, in States with Abortion Limits Twelve Reasons Women’s Health and Maternal Mortality Will Not Worsen, and May Improve, in States with Abortion Limits
Reset All Filters
3 results
amicus brief

Scientists Ask U.S. District Court to Suspend Sale of Dangerous, Poorly Tested Abortion Pills

With major international studies showing that the abortion pill regimen carries four times the risk of complications as surgical abortion, Charlotte Lozier Institute has filed an amicus brief asking the U.S. District Court for the Northern District of Texas to grant a preliminary injunction suspending the Food and Drug Administration’s (FDA) approval of the abortion pill. 

charlotte-lozier-institute Charlotte Lozier Institute
February 14, 2023
ClosePlease loginn
amicus brief

Lozier Institute Amicus Brief in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration

The U.S. Food & Drug Administration (FDA) claims that “[b]enefit-risk assessment is the foundation for” the agency’s “regulatory review of human drugs and biologics.” But when it comes to abortion regulation, particularly chemical abortion regulation, that foundation is severely compromised.

featured-image
amicus brief

PRESS RELEASE: Lozier Scholar Submits Amicus Brief in Little Sisters Case

Michael New, Ph.D., an Associate Scholar with the Charlotte Lozier Institute, the education arm of Susan B. Anthony List, submitted

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image